NBE-Therapeutics
Research in cancer treatment
NBE-Therapeutics has raised €62M across 4 funding rounds from 3 investors, most recently a Series C round in Oct 2020. Based in Basel, Switzerland; founded 2012; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€62M
€61,525,600
Funding rounds
4
Investors
3
distinct backers
Active since
2015-03
latest 2020-10
Funding by year
EUR raised per yearNBE-Therapeutics — funding by year — interactive chart.
Data table
| NBE-Therapeutics — funding by year | |
|---|---|
| 2015 | €2.8M |
| 2016 | €19M |
| 2020 | €40M |
Signals
High confidenceRaise-next likelihood10
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
Exit likelihood11
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 4 rounds raised
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-10-01 | Series C | €19M | Boehringer Ingelheim Venture Fund,PPF Group | View deal → |
| 2020-09-10 | Other | €21M | — | View deal → |
| 2016-11-01 | Series B | €19M | Boehringer Ingelheim Venture Fund,PPF Group | View deal → |
| 2015-03-01 | Series A | €2.8M | Boehringer Ingelheim Venture Fund | View deal → |
Related news
Similar companies
same sector, similar size- Pharvaris€67MSwitzerland · Healthtech
- Monte Rosa€80MSwitzerland · Healthtech
- Anjarium Biosciences€51MSwitzerland · Healthtech
- Numab€74MSwitzerland · Healthtech
- Endosense€59MSwitzerland · Healthtech
- Ava€39MSwitzerland · Healthtech
Global coverage: FundingData